Effect of KA-EX Supplementation on Recovery Parameters in High-Level Young Football Players
Condition(s) studied
Investigational drug(s) / intervention(s)
KA-EX: Powder sachet to be dissolved in water. Contains a patented complex of amino acids, electrolytes, and carbohydrates designed to normalize cortisol and support recovery.
Experimental: KA-EX Supplement: Powder sachet with identical organoleptic characteristics but without the active recovery ingredients of KA-EX.
Study summary
The purpose of this study is to evaluate the effects of KA-EX supplementation on recovery parameters in elite young football players. Athletes from the Udine Primavera team will be randomly assigned to receive either the KA-EX supplement or a sensory-matched placebo immediately following their training sessions for a period of two months.
The researchers will monitor heart rate variability (HRV) and sleep quality using Garmin wearable devices, and assess changes in body composition using Dual-energy X-ray absorptiometry (DEXA) and bioelectrical impedance analysis (BIA). The goal of the study is to determine if post-training KA-EX administration improves physiological recovery, sleep quality, and physical readiness in high-performance athletes during a competitive season.
Eligibility
Primary outcome measure(s)
- Change from Baseline in Heart Rate Variability (rMSSD) — Baseline and daily for 8 weeks.
Autonomic recovery assessed as Root Mean Square of Successive Differences (rMSSD) during nocturnal sleep via Garmin wearable devices. Higher values indicate better parasympathetic recovery.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Stadio BlueEnergy | Udine | Friuli Venecia |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07824752 on ClinicalTrials.gov ↗ ← All trials in Italy